A multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the use of Chinese herbal medicine in the management of endometriosis: a prospective study

Completed

• Conditions: Endometriosis; Urological and Genital Diseases

• Registration Number: ISRCTN19413357
• Lead Sponsor: niversity of Western Sydney (Australia)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-06-02
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

1. Women, aged 18 - 43 years
2. Diagnosed with endometriosis by laparoscopy and the severity staged (grade I - IV)
3. At least three months of pain measuring more than 30 mm on visual analogue scale (VAS) scale

Exclusion Criteria

1. Menopause
2. Pregnancy
3. Liver diseases
4. Suffering from diabetes mellitus
5. Suffering from malignancies
6. Hormonal treatments
7. Anti-depressant treatments
8. Immunosuppressive conditions and treatments

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain intensity due to endometriosis, measured quantitatively on the VAS and qualitatively as descriptive values.

Secondary Outcome Measures

Name	Time	Method
1. Quality of life using the 36-item Short-Form health survey (SF-36) and a study design health survey tool<br>2. Serum CA 125 levels